참고문헌
- Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M.T., Martin, T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20: 345-357, 1999 https://doi.org/10.1210/er.20.3.345
- Teitelbaum, S.L., Ross, F.P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4: 638-649, 2003 https://doi.org/10.1038/nrg1122
- Boyle, W.J., Simonet, W.S., Lacey, D.L. Osteoclast differentiation and activation. 423: 337-342, 2003
- Tolar, J., Teitelbaum, S.L., Orchard, P.J. Osteopetrosis. N. Engl. J. Med. 351: 2839-2849, 2004 https://doi.org/10.1056/NEJMra040952
- Yagi, M., Miyamoto, T., Toyama, Y., Suda, T. Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells. J. Bone Miner. Metab. 24: 355-358, 2006 https://doi.org/10.1007/s00774-006-0697-9
- Fuller, K., Wong, B., Fox, S., Choi, Y., Chambers, T.J. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J. Exp. Med. 188: 997-1001, 1998 https://doi.org/10.1084/jem.188.5.997
- Kong, Y.Y., Yoshida, H., Sarosi, I., Tan, H.L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A.J., Van, G., Itie, A., Khoo, W., Wakeham, A., Dunstan, C.R., Lacey, D.L., Mak, T.W., Boyle, W.J., Penninger, J.M. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 397: 315-323, 1999 https://doi.org/10.1038/16852
- Sato, N., Takahashi, N., Suda, K., Nakamura, M., Yamaki, M., Ninomiya, T., Kobayashi, Y., Takada, H., Shibata, K., Yamamoto, M., Takeda, K., Akira, S., Noguchi, T., Udagawa, N. MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha. J. Exp. Med. 200: 601-611, 2004 https://doi.org/10.1084/jem.20040689
- Kanematsu, M., Sato, T., Takai, H., Watanabe, K., Ikeda, K., Yamada, Y. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. J. Bone Miner. Res. 15: 1321-1389, 2000 https://doi.org/10.1359/jbmr.2000.15.7.1321
- Tsukii, K., Shima, N., Mochizuki, S., Yamaguchi, K., Kinosaki, M., Yano, K., Shibata, O., Udagawa, N., Yasuda, H., Suda, T., Higashio, K. Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. Biochem. Biophys. Res. Commun. 246: 337-341, 1998 https://doi.org/10.1006/bbrc.1998.8610
- Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7: 292-304, 2007 https://doi.org/10.1038/nri2062
- Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J., Wagner, E.F., Mak, T.W., Kodama, T., Taniguchi, T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell. 3: 889-901, 2002 https://doi.org/10.1016/S1534-5807(02)00369-6
- Kim, K., Kim, J.H., Lee, J., Jin, H.M., Lee, S.H., Fisher, D.E., Kook, H., Kim, K.K., Choi, Y., Kim, N. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J. Biol. Chem. 280: 35209-35216, 2005 https://doi.org/10.1074/jbc.M505815200
- Lloyd, M. Treatment of postmenopausal osteoporosis. N. Engl. J. Med. 338: 736-746, 1998 https://doi.org/10.1056/NEJM199803123381107
- Rodan, G.A., Martin, T.J. Therapeutic approaches to bone disease. Science. 289: 1508-1514, 2000 https://doi.org/10.1126/science.289.5484.1508
- Kwak, H.B., Yang, D., Ha, H., Lee, J.H., Kim, H.N., Woo, E.R., Lee, S., Kim, H.H., Lee, Z.H. Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1. Exp. Mol. Med. 38: 256-264, 2006 https://doi.org/10.1038/emm.2006.31
- Park, C.K., Kim, H.J., Kwak, H.B., Lee, T.H., Bang, M.H., Kim, C.M., Lee, Y., Chung, D.K., Baek, N.I., Kim, J., Lee, Z.H., Kim, H.H. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption. Int. Immunopharmacol. 7: 1507-1516, 2007 https://doi.org/10.1016/j.intimp.2007.07.016
- Li, Y.J., Kim, T.H., Kwak, H.B., Lee, Z.H., Lee, S.Y., Jhon, G.J. Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption. J. Etnopharmacol. 113: 191-198, 2007 https://doi.org/10.1016/j.jep.2007.04.020
- Kwak, H.B., Kim, J.H., Kim, D.J., Kwon, Y.M., Oh, J., Kim, Y.K. Effect of water extract of deer antler in osteoclast differentiation. Korean J. Oriental Physiology & Pathology. 22: 891-895, 2008
- Kwak, H.B., Choi, M.K. Inhibitory mechanism of curcumin in osteoclast differentiation. Korean J. Oriental Physiology & Pathology. 22: 796-501, 2008
- Jung, Y.T., Choi, Y.H., Song, J.H., Lee, C.H.. Lee, M.S., Jang, S.J., Cho, H.J., Kwak, H.B., Oh, J. Effect of water extract of eucommiae cortex in RANKL-induced osteoclast differentiation. Korean J. Oriental Physiology & Pathology. 23: 613-618, 2009
- Cho, H.J., Choi, M.K., Kim, J.J., Le, Y., Song, J.H., Lee, M.S., Lee, C.H., Jang, S.J., Kwak, H.B., Oh, J. Effect of water extracts of ccuscuta japonica chois in RANKL-induced osteoclast differentiation. Korean J. Oriental Physiology & Pathology. 23: 860-865, 2009
- Kim, Y.K., Kim, K.S., Chung, K.H., Kim, J.G., Kim, K.S., Lee, Y.C., Chang, Y.C., Kim, C.H. Inhibitory effects of deer antler aqua-acupuncture, the pilose antler of Cervus Korean TEMMINCK var mantchuricus Swinhoe, on type II collagen-induced arthritis in rats. Int. Immunopharmacol. 3: 1001-1010, 2003 https://doi.org/10.1016/S1567-5769(03)00098-5
- Zou, W., Bar-Shavit, Z. Dual modulation of osteoclast differentiation by lipopolysaccharide. J. Bone Miner. Res. 17: 1211-1218, 2002 https://doi.org/10.1359/jbmr.2002.17.7.1211
- Karsdal, M.A., Henriksen, K., Arnold, M., Christiansen, C. Calcitonin: a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone quality. BioDrugs. 22: 137-144, 2008 https://doi.org/10.2165/00063030-200822030-00001
- Lee, S.U., Park, S.J., Kwak, H.B., Oh, J., Min, Y.K., Kim, S.H. Anabolic activity of ursolic acid in bone: Stimulating osteoblast differentiation in vitro and inducing new bone formation in vivo. Pharmacol. Res. 58: 290-296, 2008 https://doi.org/10.1016/j.phrs.2008.08.008